Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tecan Group Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Tecan Group Ltd Company OverviewTecan Group Ltd Company Snapshot
Tecan Group Ltd Pipeline Products and Ongoing Clinical Trials Overview
Tecan Group Ltd – Pipeline Analysis Overview
Business Description
Tecan Group Ltd - Key Facts
Tecan Group Ltd - Major Products and Services
Tecan Group Ltd Pipeline Products by Development Stage
Tecan Group Ltd Pipeline Products Overview
17-OH-Progesterone Neonatal Screening Assay
17-OH-Progesterone Neonatal Screening Assay Product Overview
Freedom EVO With RESOLVEX A200 Workstation
Freedom EVO With RESOLVEX A200 Workstation Product Overview
Neonatal Screening Assay - Congenital Hypothyroidism
Neonatal Screening Assay - Congenital Hypothyroidism Product Overview
Next Generation Molecular Diagnostics
Next Generation Molecular Diagnostics Product Overview
Tecan Group Ltd - Key Competitors
Tecan Group Ltd - Key Employees
Tecan Group Ltd - Key Employee Biographies
Tecan Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tecan Group Ltd,
Recent Developments
Jul 03, 2018: Tecan's Spark reader aiding research into rare skin disease
Jan 25, 2018: Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories
Oct 06, 2017: Tecan initiates succession process for the Board of Directors
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan
Jan 10, 2017: Tecan appoints Klaus Lun Head of the Life Sciences Business division
Dec 14, 2016: Tecan announces change in Management Board
Mar 18, 2015: Tecan with strong order entry and good sales development in the second half of
Appendix
Methodology
About
Contact Us
Disclaimer
List of Tables
Tecan Group Ltd Pipeline Products and Ongoing Clinical Trials Overview
Tecan Group Ltd Pipeline Products by Equipment Type
Tecan Group Ltd Pipeline Products by Indication
Tecan Group Ltd, Key Facts
Tecan Group Ltd, Major Products and Services
Tecan Group Ltd Number of Pipeline Products by Development Stage
Tecan Group Ltd Pipeline Products Summary by Development Stage
17-OH-Progesterone Neonatal Screening Assay - Product Status
17-OH-Progesterone Neonatal Screening Assay - Product Description
Freedom EVO With RESOLVEX A200 Workstation - Product Status
Freedom EVO With RESOLVEX A200 Workstation - Product Description
Neonatal Screening Assay - Congenital Hypothyroidism - Product Status
Neonatal Screening Assay - Congenital Hypothyroidism - Product Description
Next Generation Molecular Diagnostics - Product Status
Next Generation Molecular Diagnostics - Product Description
Tecan Group Ltd, Key Employees
Tecan Group Ltd, Key Employee Biographies
Tecan Group Ltd, Subsidiaries
Glossary
List of Figures
Tecan Group Ltd Pipeline Products by Equipment Type
Tecan Group Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Qiagen NV
- Hudson Robotics Inc
- Buchi Labortechnik AG
- BioTek Instruments Inc
- Analytik Jena AG
